Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
UNITED STATES OF AMERICA ex rel. YOASH GOHIL v. AVENTIS PHARMACEUTICALS, INC. et al
Case Number:
2:02-cv-02964
Court:
Nature of Suit:
Other Statutes: Other Statutory Actions
Judge:
Firms
- Armstrong Teasdale
- Arnold & Porter
- Blank Rome
- Hamburg & Golden
- Hogan Lovells
- Montgomery McCracken
- Shook Hardy
Companies
Sectors & Industries:
-
November 08, 2021
Sanofi, Whistleblower Settle 19-Year Cancer Drug FCA Battle
A whistleblower has voluntarily dropped his 19-year-old False Claims Act lawsuit alleging the drugmaker Sanofi U.S. Services Inc. misleadingly promoted off-label uses for its cancer therapy drug, after the parties reached a confidential settlement less than three months before the case was set for trial.
-
November 12, 2020
Sanofi Must Face Cancer Drug FCA Claims At Trial
A Pennsylvania federal judge on Thursday handed drugmaker Sanofi U.S. Services Inc. a win on some allegations in a whistleblower's 18-year-old False Claims Act lawsuit, but allowed other claims that the drugmaker misleadingly promoted off-label uses for its cancer therapy drug to head to trial.
-
April 17, 2020
Pa. Judge Rips Aventis' Last-Minute Subpoenas In FCA Fight
A Pennsylvania federal judge tore into drugmaker Aventis for a last-minute motion to compel discovery in an 18-year-old false claims case, explaining Friday that she denied the motion in March because Aventis could have and should have made it before the closure of more than four years of discovery.
-
September 30, 2019
Ex-Sanofi Employee Says Doctor Program Was For Kickbacks
A former Sanofi U.S. Services Inc. employee urged a Pennsylvania federal judge to find that an incentive program by the drugmaker was a kickback scheme, arguing the company's own documents show the program's purpose was to get doctors to prescribe a Sanofi medication for unapproved uses.
-
May 22, 2018
Sanofi Must Divulge Docs In FCA Fight Over Cancer Drug
A Pennsylvania federal judge has ordered Sanofi to hand over hundreds of documents, including any warnings that food and drug regulators may have issued, said to pertain to a suit alleging it marketed off-label uses of a cancer drug.
-
April 13, 2018
Sanofi's FCA Suit Docs Not All Privileged, Ex-Worker Says
A whistleblower told a Pennsylvania federal court Thursday that Sanofi should be required to hand over in discovery hundreds of documents it claims are protected by attorney-client privilege in a suit alleging it unlawfully marketed off-label uses of a cancer drug, violating the False Claims Act.
-
January 10, 2017
Sanofi Can't Ditch Ex-Worker's FCA Claims Over Cancer Drug
Sanofi on Monday lost a bid to dodge False Claims Act allegations that it unlawfully marketed off-label uses of a cancer drug when a Pennsylvania federal judge said there was a genuine dispute over whether the marketing was false or misleading.